Literature DB >> 628310

The effects of phencyclidine on operant behavior in the rat: biphasic effect and tolerance development.

T F Murray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628310     DOI: 10.1016/0024-3205(78)90537-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Situational specificity of tolerance to effects of phencyclidine on responding of rats under fixed-ratio and spaced-responding schedules.

Authors:  J B Smith
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Self-administration of orally-delivered phencyclidine and ethanol under concurrent fixed-ratio schedules in rhesus monkeys.

Authors:  M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Tolerance to the behavioral effects of phencyclidine: the importance of behavioral and pharmacological variables.

Authors:  W L Woolverton; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

4.  Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.

Authors:  G C Wagner; D B Masters; A Tomie
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Acute and chronic phencyclidine administration effects on the conversion of 3H-tryptophan to 3H-serotonin in rat forebrain.

Authors:  K M Johnson
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

6.  Behavioral effects of chronic phencyclidine administration in rats.

Authors:  R D Sturgeon; R G Fessler; S F London; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice.

Authors:  Y Noda; K Yamada; Y Komori; H Sugihara; H Furukawa; T Nabeshima
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.